SETD2 and gastric adenocarcinoma: Further analysis showed that a SETD2 deleterious mutation was an independent factor influencing MSI-H in colorectal carcinoma (P < 0.0001) and stomach adenocarcinoma (P = 0.003) (Fig. 3B).